Article Versions Notes

Schmitz E, Ridout A, Smith AL, Eiken AP, Skupa SA, Drengler EM, Singh S, Rana S, Natarajan A, El-Gamal D. Immunogenic Cell Death Traits Emitted from Chronic Lymphocytic Leukemia Cells Following Treatment with a Novel Anti-Cancer Agent, SpiD3. Biomedicines. 2024; 12(12):2857. https://doi.org/10.3390/biomedicines12122857

Schmitz, Elizabeth, Abigail Ridout, Audrey L. Smith, Alexandria P. Eiken, Sydney A. Skupa, Erin M. Drengler, Sarbjit Singh, Sandeep Rana, Amarnath Natarajan, and Dalia El-Gamal. 2024. "Immunogenic Cell Death Traits Emitted from Chronic Lymphocytic Leukemia Cells Following Treatment with a Novel Anti-Cancer Agent, SpiD3" Biomedicines 12, no. 12: 2857. https://doi.org/10.3390/biomedicines12122857

Schmitz, E., Ridout, A., Smith, A. L., Eiken, A. P., Skupa, S. A., Drengler, E. M., Singh, S., Rana, S., Natarajan, A., & El-Gamal, D. (2024). Immunogenic Cell Death Traits Emitted from Chronic Lymphocytic Leukemia Cells Following Treatment with a Novel Anti-Cancer Agent, SpiD3. Biomedicines, 12(12), 2857. https://doi.org/10.3390/biomedicines12122857